EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive’ ...

A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

Obesity, diabetes and cardiovascular diseases are increasingly present in the population. Brown adipose tissue has a ...

China is a one of the most important regions for the booming obesity market, thanks to government incentives and changing ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

In children with undernutrition, increasing weight in a child's first decade of life can lead to significantly taller ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

A groundbreaking initiative is taking flight in west Louisville, targeted at combating one of the community's most pressing health issues: childhood obesity.